Blackston Financial Advisory Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-511
Closed -$395K 119
2024
Q4
$395K Buy
511
+72
+16% +$59.6K 0.2% 77
2024
Q3
$389K Buy
439
+170
+63% +$153K 0.2% 75
2024
Q2
$244K Buy
+269
New +$215K 0.14% 66

Other funds holding LLY

Blackston Financial Advisory Group's LLY Position: Q1 2025 in Review

Blackston Financial Advisory Group sold out of Eli Lilly (LLY) in Q1 2025, closing a stake of 511 shares — an estimated $395K sold.

Blackston Financial Advisory Group first reported a position in LLY in Q2 2024 and held it in 3 quarters. The position peaked at $395K in Q4 2024. 3,920 funds tracked by Wall St. Rank hold LLY as of Q1 2025.

  • Blackston Financial Advisory Group reported no remaining Eli Lilly position as of Q1 2025 after selling out during the quarter.
  • Blackston Financial Advisory Group sold 511 Eli Lilly shares in Q1 2025, an estimated $395K.
  • Blackston Financial Advisory Group first reported a position in Eli Lilly in Q2 2024 and held it in 3 quarters.
  • Blackston Financial Advisory Group's Eli Lilly position peaked at $395K in Q4 2024.
  • 3,920 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2025.

Based on Blackston Financial Advisory Group's 13F filing for Q1 2025, filed 17 Apr 2025.